| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/11/2010 | US20100062048 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds |
| 03/11/2010 | US20100062041 Skin sunstitutes, preparation methods and uses thereof |
| 03/11/2010 | CA2735825A1 Hair growth promoting agent containing 15,15-difluoroprostaglandin f2.alpha. derivative as active ingredient |
| 03/10/2010 | EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications |
| 03/10/2010 | EP2161265A2 Compounds having selective inhibiting effect at GSK3 |
| 03/10/2010 | EP2161252A1 N-Alkylcarbonyl-amino acid ester and N-Alkylcarbonyl-amino lactone compounds and their use |
| 03/10/2010 | EP2161032A2 Methods of healing wounds by administering human IL-18 |
| 03/10/2010 | EP2160190A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
| 03/10/2010 | EP1605964B1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/10/2010 | CN100593418C Spray for treating burn |
| 03/09/2010 | US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors |
| 03/09/2010 | US7674777 Immunostimulatory nucleic acid molecules |
| 03/09/2010 | US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/09/2010 | US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | US7674451 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 03/09/2010 | CA2411922C Composition for pain mediation and apparatus and method of use thereof |
| 03/09/2010 | CA2379282C Amido spiropiperidines promote the release of growth hormone |
| 03/09/2010 | CA2301616C Dermatological compositions comprising microbial proliferation inhibitors |
| 03/04/2010 | WO2010025438A2 Methods of treatment using single doses of oritavancin |
| 03/04/2010 | WO2010025430A2 Homeopathic therapeutic method |
| 03/04/2010 | WO2010025314A2 Prevention and treatment of itch with cysteine protease inhibition |
| 03/04/2010 | WO2010025201A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 03/04/2010 | WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same |
| 03/04/2010 | WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity |
| 03/04/2010 | WO2010024204A1 Wrinkle-diminishing agent |
| 03/04/2010 | WO2010023390A1 Use of an n-acyl amino acid selected from among n-palmitoyl alanine, n-palmitoyl glycine, and n-palmitoyl isoleucine as a regulating active agent of the genetic profile of senescent replicating fibroblasts of the human skin dermis |
| 03/04/2010 | WO2010023317A1 Novel hexafluoro-2-biphenylisopropanol compounds that modulate lxr-type receptors, process for the preparation thereof and use thereof as medicaments in human and veterinary medicine and also in cosmetics |
| 03/04/2010 | WO2010023274A2 Composition for the treatment of alopecia |
| 03/04/2010 | WO2010022725A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 03/04/2010 | WO2010000686A3 Composition for topical use comprising quinine |
| 03/04/2010 | WO2009146131A3 Compositions for prevention/prophylactic treatment of poison ivy dermatitis |
| 03/04/2010 | WO2009144712A8 Pediculicide compositions |
| 03/04/2010 | WO2009083768A3 Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions |
| 03/04/2010 | WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/04/2010 | WO2009003284A8 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 03/04/2010 | US20100056982 Photodynamic therapy for the treatment of acne |
| 03/04/2010 | US20100056644 Pharmaceutical compositions containing anhydrous calcipotriene |
| 03/04/2010 | US20100056626 Cosmetic product for the treatment of cicatricial tissues |
| 03/04/2010 | US20100056615 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders |
| 03/04/2010 | US20100056585 N-(2-Aminophenyl)-4-[N-(Pyridine-3-yl)-Methoxycarbonyl-Aminomethyl]-Benzamide (MS-275) Polymorph B |
| 03/04/2010 | US20100056462 Medical composition for promotion of skin regeneration |
| 03/04/2010 | US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/04/2010 | US20100056432 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2010 | US20100056424 Cosmetic use of chitinase-type proteins |
| 03/04/2010 | US20100056423 Bacterial-Derived BLIS for Treatment of Acne |
| 03/04/2010 | US20100055789 Method and apparatus for the stimulation of hair growth |
| 03/04/2010 | US20100055220 Skin external preparation in the form of water-in-oil emulsion comprising ceramide |
| 03/04/2010 | US20100055205 Functional consumable compositions for promoting skin health and methods for using the same |
| 03/04/2010 | US20100055163 Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes |
| 03/04/2010 | US20100055161 Hydrogel face mask for delivering skin care agents |
| 03/04/2010 | US20100055160 Analgesic anti-inflammatory patches for topical use |
| 03/04/2010 | US20100055158 Environmentally Activated Compositions, Articles and Methods |
| 03/04/2010 | US20100055153 Multipurpose hydrogel compositions and products |
| 03/04/2010 | US20100055137 Microemulsion & sub-micron emulsion process & compositions |
| 03/04/2010 | US20100055088 CXCR4 Antagonists for Wound Healing and Re-Epithelialization |
| 03/04/2010 | DE202009016205U1 Zusammensetzung zur topischen Anwendung A composition for topical application |
| 03/04/2010 | DE102008045194A1 Medizinisches Präparat auf pflanzlicher Basis Medical preparation plant-based |
| 03/04/2010 | CA2736860A1 Methods of treatment using single doses of oritavancin |
| 03/04/2010 | CA2735155A1 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
| 03/04/2010 | CA2734551A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 03/04/2010 | CA2734502A1 Homeopathic therapeutic method |
| 03/03/2010 | EP2158909A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 03/03/2010 | EP2158907A2 A composition for use as a medicament for topical application to skin |
| 03/03/2010 | EP2158906A1 Composition for the treatment of alopecia |
| 03/03/2010 | EP2157978A2 Mc-1 r, mc-2 r, and mu opioid receptors modulation |
| 03/03/2010 | EP1743648B1 Method for treating inflammation |
| 03/03/2010 | EP1631295B1 Use of condensed heterocyclic compounds as scce inhibitors for the treatment of skin diseases |
| 03/03/2010 | EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics |
| 03/03/2010 | EP1505973B1 Combinations for treating multiple myeloma |
| 03/03/2010 | EP1401421B1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | CN100592905C Pet food composition for skin photoprotection |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671071 Crystal structure; antihistamines; histamine H1-antagonists; side effect reduction; storage stability |
| 03/02/2010 | US7671009 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 03/02/2010 | US7670620 Topical composition for the treatment of psoriasis and related skin disorders |
| 02/25/2010 | WO2010022358A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoio[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | WO2010022177A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 02/25/2010 | WO2010021579A1 Anti-infective compounds and uses thereof |
| 02/25/2010 | WO2010021129A1 Apoptosis inhibitor |
| 02/25/2010 | WO2010021117A1 Internal preparation for achieving beautiful skin containing milk serum kefir as the active ingredient |
| 02/25/2010 | WO2010021034A1 Skin preparation for external use |
| 02/25/2010 | WO2010020593A1 Treatment of an autoimmune disease using il-18 antagonists |
| 02/25/2010 | WO2010020379A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 02/25/2010 | WO2010020247A1 Multilayered blood product |
| 02/25/2010 | WO2010020165A1 Promotors of ceramide’s generation |
| 02/25/2010 | WO2010001258A3 Inhibition of tumour growth and metastases |
| 02/25/2010 | WO2009156677A3 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 02/25/2010 | WO2009087242A3 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
| 02/25/2010 | US20100048725 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 02/25/2010 | US20100048703 Hair care product |
| 02/25/2010 | US20100048702 Prevention of neutrophil recruitment |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048659 Aqueous compositions containing metronidazole |
| 02/25/2010 | US20100048651 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 02/25/2010 | US20100048627 synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 02/25/2010 | US20100048617 Compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |